๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

12 recruiting trials

for Sickle Cell Trait

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] NCT06923111n/a12 sites๐Ÿ“ Hamburg๐Ÿ“ Heidelberg๐Ÿ“ Basildon Nova Laboratories Limited ยท Tests: Xromi Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait NCT07083531n/a1 site๐Ÿ“ Farmington UConn Health ยท Tests: Healthy volunteers without SCT, Healthy volunteers with SCT Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT) NCT06071377n/a8 sites๐Ÿ“ Birmingham๐Ÿ“ Wilmington๐Ÿ“ Indianapolis National Alliance for Sickle Cell Centers ยท Tests: Biologic Specimen Collection A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD NCT04201210Phase 29 sites๐Ÿ“ Vienna๐Ÿ“ Aachen๐Ÿ“ Berlin University of Regensburg ยท Tests: TCRฮฑ/ฮฒ+ and CD19+ depleted haploidentical stem cell transplantation, Matched sibling donor transplantation Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease NCT03685721n/a1 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease NCT05904093Phase 11 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) ยท Tests: Fostamatinib Uganda Sickle Surveillance Study (US-3) NCT06301893n/a4 sites๐Ÿ“ Kampala๐Ÿ“ Kampala๐Ÿ“ Kampala Children's Hospital Medical Center, Cincinnati Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders NCT04416178n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Sickle Cell Kidney Biorepository NCT07064174n/a2 sites๐Ÿ“ Dallas๐Ÿ“ Dallas University of Texas Southwestern Medical Center 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD) NCT07015684Phase 11 site๐Ÿ“ New York Columbia University ยท Tests: 131I-apamistmab, Sirolimus, Campath, Total Body Irradiation, Exchange Transfusion A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) NCT06439082Phase 336 sites๐Ÿ“ Birmingham๐Ÿ“ Orange๐Ÿ“ Washington D.C. Novartis Pharmaceuticals ยท Tests: Crizanlizumab, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy